Semler Scientific, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SMLR research report →
Companywww.semlerscientific.com
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
- CEO
- Douglas Murphy-Chutorian
- IPO
- 2014
- Employees
- 79
- HQ
- Santa Clara, CA, US
Price Chart
Valuation
- Market Cap
- $310.75M
- P/E
- 6.24
- P/S
- 8.41
- P/B
- 0.66
- EV/EBITDA
- -8.94
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 90.76%
- Op Margin
- -94.71%
- Net Margin
- 130.80%
- ROE
- 15.65%
- ROIC
- -4.62%
Growth & Income
- Revenue
- $56.29M · -17.44%
- Net Income
- $40.90M · 98.70%
- EPS
- $5.66 · 84.97%
- Op Income
- $20.93M
- FCF YoY
- -1073.05%
Performance & Tape
- 52W High
- $65.98
- 52W Low
- $14.88
- 50D MA
- $20.31
- 200D MA
- $30.26
- Beta
- 1.32
- Avg Volume
- 647.86K
Get TickerSpark's AI analysis on SMLR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 16, 26 | SEMLER ERIC | sell | 75,000 |
| Jan 16, 26 | SEMLER ERIC | sell | 150,000 |
| Jan 16, 26 | SEMLER ERIC | sell | 12,375 |
| Jan 16, 26 | SEMLER ERIC | sell | 4,000 |
| Jan 16, 26 | SEMLER ERIC | sell | 77,771 |
| Jan 16, 26 | Murphy-Chutorian Douglas | sell | 25,000 |
| Jan 16, 26 | Murphy-Chutorian Douglas | sell | 50,000 |
| Jan 16, 26 | Murphy-Chutorian Douglas | sell | 15,000 |
| Jan 16, 26 | Murphy-Chutorian Douglas | sell | 15,000 |
| Jan 16, 26 | Murphy-Chutorian Douglas | sell | 125,000 |
Our SMLR Coverage
We haven't published any research on SMLR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SMLR Report →